IMI Trials@Home

Trials@Home aims to reshape clinical trial design, conduct and operations, by developing and piloting standards, recommendations and tools for the definition and operationalisation of decentralised clinical trials (DCTs) in Europe.

The Trials@Home consortium will explore the opportunities of moving clinical trials from the traditional clinic setting to the participant’s immediate surroundings. These so-called Decentralised Clinical Trials (DCTs) make use of new – digital – innovations and enable participants to visit a clinical trial centre less frequently, if at all.